Objective
Viral hepatitis is known to be caused by a number of viruses, each with its own distinct mode of transmission and replication. On April of this year, a new virus has presented in a congrcss in Washington the "GBV" (RNA virus, Flavivirus-like) with 3 known subtypes (A, B and C). HGV is another Flavivirus discovered recently which is able to develop hepatitis. The aim of the study is to investigate the medical, epidemiological and pathological behaviour of these new viruses using sera collected in the host laboratory during several years.
WORK PROGRAM: 1. To discriminate by ELISA using synthetic peptides immune reactive sera against "GBV" in several risk groups. Also studies concerning the GBV transmission will be performed.
2. RT-PCR method will be used to detect HGV or HGV genome
presence in sera, liver and lymphocytes in patients diagnosed of non A-E hepatitis. Positive and negative strands will be investigated. 3. The effect of interferon treatment on HGV or GBV replication will also be studied retrospectively by PCR in patients with HBV or HCV coinfection. 4. Finally, the role of these viruses in hepatocarcinoma and cirrhosis will be investigated.
This is an important opportunity for the proposer and the host laboratory to contribute at the understanding of a problem of pivotal relevance for public health in the world. With this project, we will contribute not only to further knowledge about hepatitis viruses but also our hospital will be one of the first hospitals in Spain and Europe in which GBV and HGV tests will be available with a lot of consequences in the sanitary system.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences public health
- natural sciences biological sciences microbiology virology
- medical and health sciences health sciences infectious diseases DNA viruses hepatitis B
- medical and health sciences health sciences infectious diseases RNA viruses hepatitis C
- medical and health sciences clinical medicine hepatology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
18071 GRANADA
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.